Abexxa Biologics
Pharmaceuticals, 300 South Cooper St, Arlington, Texas, 76019, United States, 11-50 Employees
Phone Number: 81********
Who is ABEXXA BIOLOGICS
Abexxa Biologics is a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused...
Read More
-
Headquarters: 300 South Cooper St, Arlington, Texas, 76019, United States
-
Date Founded: 2016
-
Employees: 11-50
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 325412 |
Show More
Does something look wrong? Fix it. | View contact records from ABEXXA BIOLOGICS
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Abexxa Biologics
Answer: Abexxa Biologics's headquarters are located at 300 South Cooper St, Arlington, Texas, 76019, United States
Answer: Abexxa Biologics's phone number is 81********
Answer: Abexxa Biologics's official website is https://abexxa.com
Answer: Abexxa Biologics's revenue is $1 Million to $5 Million
Answer: Abexxa Biologics's SIC: 2834
Answer: Abexxa Biologics's NAICS: 325412
Answer: Abexxa Biologics has 11-50 employees
Answer: Abexxa Biologics is in Pharmaceuticals
Answer: Abexxa Biologics contact info: Phone number: 81******** Website: https://abexxa.com
Answer: Abexxa Biologics is a biopharmaceutical company taking a new approach in the fields of immuno-oncology and oncology to develop the next generation of precision medicine. Abexxa is focused on developing novel therapeutics around its newly discovered class of intracellular antigens (atypical HLA-peptide complexes) on cancerous cells. These atypical HLA-peptide complexes provide access to previously un-druggable targets and have been shown to play a regulatory role in modulating innate and adaptive immune responses. Abexxa has developed a target discovery and validation platform, and a robust method to create highly specific human antibodies to those targets. These are being developed for various therapeutic drug formats, including direct tumor killing as well as mediating tumor death through immune modulation.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month